Gilead will have enough global supply of its coronavirus treatment remdesivir by the end of October, CEO Daniel O’Day told CNBC on Friday. Source

JOIN NCOV.LINK NEWSLETTER

And get notified everytime we publish a new Important announcements. We will not email you often, unless there are important things that need to get in touch with you, such as added new tools or new domain names.